Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

Published Date: 02 Oct 2025

Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell lung cancer were reported ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

4.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

5.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot